2014 60P/USAMMDA Tafenoquine CRADA

Remington Nevin filed this request with the U.S. Army Medical Materiel Development Activity of the United States of America.
Status
Completed

Communications

From: Remington Nevin

Ms. Tara M. Mose
FOIA Officer, U.S. Army Medical Materiel Development Activity (USAMMDA)
Phone: 301-619-7840
Fax: 301-619-2304
Email: Tara.M.Mose.civ@mail.mil
CC: sandra.j.rogers28.civ@mail.mil

c/o

CDR USAMMDA
ATTN: MCMR-UMS
622 Neiman Street
Fort Detrick, MD 21702-5009

Re: FOIA Request

Dear Ms. Mose,

This is a request under the Freedom of Information Act. I hereby request the following records:

The complete text, together with any appendices, of the signed 2014 Cooperative Research and Development Agreement (CRADA) between 60 Degrees Pharmaceuticals (60P) and the U.S. Army Medical Materiel Development Activity (USAMMDA) to develop tafenoquine as a weekly prophylactic drug for the prevention of malaria.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Dr. Remington Nevin

From: U.S. Army Medical Materiel Development Activity

Classification: UNCLASSIFIED
Caveats: NONE

Dr. Nevin

Please see attached response and requested documents for your FOIA request.
Please let me know when you receive this.

v/r
Sandra

Files

pages

Close